[July 29, 2016] |
|
World Poly Adenosine Diphosphate Ribose Polymerase Inhibitors Pipeline Insights Market Report 2016 - Research and Markets
Research and Markets has announced the addition of the "Poly
Adenosine Diphosphate (ADP) Ribose Polymerase (PARP) Inhibitors
-Pipeline Insights, 2016" report to their offering.
Poly Adenosine Diphosphate Ribose Polymerase Inhibitors-Pipeline
Insights, 2016 provides in depth insights on the pipeline drugs and
their development activities around the Poly Adenosine Diphosphate
Ribose Polymerase Inhibitors. The report covers the product profiles in
various stages of development including Discovery, Pre-clinical, IND,
Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
The report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for Poly Adenosine
Diphosphate Ribose Polymerase Inhibitors.
The report also assesses the Poly Adenosine Diphosphate Ribose
Polymerase Inhibitors therapeutics by Monotherapy, Combination products,
molecule type and Route of Administration.
Scope
-
The report provides competitive pipeline landscape of Poly Adenosine
Diphosphate Ribose Polymerase Inhibitors
-
The report provides pipeline products under drug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
-
Coverage of the Poly Adenosine Diphosphate Ribose Polymerase
Inhibitors pipeline on the basis of target, MOA, route of
administration, technology involved and molecule type
-
The report reviews key players involved in the therapeutics
development for Poly Adenosine Diphosphate Ribose Polymerase
Inhibitors and also provide company profiling
-
The report also gives the information of dormant and discontinued
pipeline projects
-
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Overview
-
Pipeline Therapeutics
-
Therapeutics under Development by Companies
-
Filed and Phase III Products
-
Comparative Analysis
-
Phase II Products
-
Comparative Analysis
-
Phase I and IND Filed Products
-
Comparative Analysis
-
Discovery and Pre-Clinical Stage Products
-
Comparative Analysis
-
Drug Candidate Profiles
-
Therapeutics Assessment
-
Assessment by Monotherapy Products
-
Assessment by Combination Products
-
Assessment by Route of Administration
-
Assessment by Molecule Type
-
Discontinued Products
-
Dormant Products
-
Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/9rvqp4/poly_adenosine
View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005705/en/
[ Back To TMCnet.com's Homepage ]
|